Innate immunity in Alzheimer's disease: a model for local inflammatory reactions - PubMed (original) (raw)
Affiliations
- PMID: 14993335
Review
Innate immunity in Alzheimer's disease: a model for local inflammatory reactions
E G McGeer et al. Mol Interv. 2001 Apr.
Abstract
Over the past fifteen years, evidence has been accumulating that there is a chronic inflammatory reaction in areas of the brain affected by Alzheimer's disease. Chronic inflammation, which arises in reaction to an underlying pathology, represents a threat in its own right, wherever it may occur, and can in fact surpass primary affronts upon tissues. The brain, however, is particularly vulnerable because neurons are generally irreplaceable. In the case of Alzheimer's disease, inflammatory processes thus have the potential for turning a relatively slowly progressing condition into one characterized by rapid neurodegeneration.
Similar articles
- Innate immunity, local inflammation, and degenerative disease.
McGeer PL, McGeer EG. McGeer PL, et al. Sci Aging Knowledge Environ. 2002 Jul 24;2002(29):re3. doi: 10.1126/sageke.2002.29.re3. Sci Aging Knowledge Environ. 2002. PMID: 14602998 Review. - The immune system, amyloid-beta peptide, and Alzheimer's disease.
Weksler ME, Gouras G, Relkin NR, Szabo P. Weksler ME, et al. Immunol Rev. 2005 Jun;205:244-56. doi: 10.1111/j.0105-2896.2005.00264.x. Immunol Rev. 2005. PMID: 15882358 Review. - Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
Montalto MC, Farrar G, Hehir CT. Montalto MC, et al. Ann N Y Acad Sci. 2007 Feb;1097:239-58. doi: 10.1196/annals.1379.023. Ann N Y Acad Sci. 2007. PMID: 17413026 Review. - Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease.
Shepherd CE, Gregory GC, Vickers JC, Halliday GM. Shepherd CE, et al. Neuropathol Appl Neurobiol. 2005 Oct;31(5):503-11. doi: 10.1111/j.1365-2990.2005.00667.x. Neuropathol Appl Neurobiol. 2005. PMID: 16150121 - Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
Dudal S, Krzywkowski P, Paquette J, Morissette C, Lacombe D, Tremblay P, Gervais F. Dudal S, et al. Neurobiol Aging. 2004 Aug;25(7):861-71. doi: 10.1016/j.neurobiolaging.2003.08.008. Neurobiol Aging. 2004. PMID: 15212840
Cited by
- Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study.
Cribbs DH, Berchtold NC, Perreau V, Coleman PD, Rogers J, Tenner AJ, Cotman CW. Cribbs DH, et al. J Neuroinflammation. 2012 Jul 23;9:179. doi: 10.1186/1742-2094-9-179. J Neuroinflammation. 2012. PMID: 22824372 Free PMC article. - The effect of age on the gingival crevicular fluid composition during experimental gingivitis. A pilot study.
Tsalikis L. Tsalikis L. Open Dent J. 2010 Mar 1;4:13-26. doi: 10.2174/1874210601004010013. Open Dent J. 2010. PMID: 20502645 Free PMC article. - Role of Withaferin A and Its Derivatives in the Management of Alzheimer's Disease: Recent Trends and Future Perspectives.
Das R, Rauf A, Akhter S, Islam MN, Emran TB, Mitra S, Khan IN, Mubarak MS. Das R, et al. Molecules. 2021 Jun 17;26(12):3696. doi: 10.3390/molecules26123696. Molecules. 2021. PMID: 34204308 Free PMC article. Review. - Differential effects of amyloid-β peptide aggregation status on in vivo retinal neurotoxicity.
Watts HR, Anderson P, Ma D, Philpott KL, Jen SM, Croucher M, Jen LS, Gentleman SM. Watts HR, et al. Eye Brain. 2010 Sep 9;2:121-137. doi: 10.2147/eb.s9902. eCollection 2010. Eye Brain. 2010. PMID: 28539771 Free PMC article. - Fibrillar amyloid-beta-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer's disease.
Jana A, Pahan K. Jana A, et al. J Neurosci. 2010 Sep 22;30(38):12676-89. doi: 10.1523/JNEUROSCI.1243-10.2010. J Neurosci. 2010. PMID: 20861373 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous